Literature DB >> 14530299

Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1.

Alan Lee1, Wenjun Li, Kanyan Xu, Brigitte A Bogert, Kimmy Su, Fen-Biao Gao.   

Abstract

Fragile X syndrome is caused by loss-of-function mutations in the fragile X mental retardation 1 gene. How these mutations affect neuronal development and function remains largely elusive. We generated specific point mutations or small deletions in the Drosophila fragile X-related (Fmr1) gene and examined the roles of Fmr1 in dendritic development of dendritic arborization (DA) neurons in Drosophila larvae. We found that Fmr1 could be detected in the cell bodies and proximal dendrites of DA neurons and that Fmr1 loss-of-function mutations increased the number of higher-order dendritic branches. Conversely, overexpression of Fmr1 in DA neurons dramatically decreased dendritic branching. In dissecting the mechanisms underlying Fmr1 function in dendrite development, we found that the mRNA encoding small GTPase Rac1 was present in the Fmr1-messenger ribonucleoprotein complexes in vivo. Mosaic analysis with a repressor cell marker (MARCM) and overexpression studies revealed that Rac1 has a cell-autonomous function in promoting dendritic branching of DA neurons. Furthermore, Fmr1 and Rac1 genetically interact with each other in controlling the formation of fine dendritic branches. These findings demonstrate that Fmr1 affects dendritic development and that Rac1 is partially responsible for mediating this effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530299     DOI: 10.1242/dev.00792

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  104 in total

1.  Pathogenic polyglutamine proteins cause dendrite defects associated with specific actin cytoskeletal alterations in Drosophila.

Authors:  Sung Bae Lee; Joshua A Bagley; Hye Young Lee; Lily Yeh Jan; Yuh-Nung Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  hnRNP Q regulates Cdc42-mediated neuronal morphogenesis.

Authors:  Hung-Hsi Chen; Hsin-I Yu; Wen-Cheng Chiang; Yu-De Lin; Ben-Chang Shia; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2012-04-09       Impact factor: 4.272

Review 3.  Fragile X: leading the way for targeted treatments in autism.

Authors:  Lulu W Wang; Elizabeth Berry-Kravis; Randi J Hagerman
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 4.  Fragile X syndrome and targeted treatment trials.

Authors:  Randi Hagerman; Julie Lauterborn; Jacky Au; Elizabeth Berry-Kravis
Journal:  Results Probl Cell Differ       Date:  2012

5.  Fragile X mental retardation protein controls trailer hitch expression and cleavage furrow formation in Drosophila embryos.

Authors:  Kate Monzo; Ophelia Papoulas; Greg T Cantin; Yan Wang; John R Yates; John C Sisson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

6.  Molecular and genetic analysis of the Drosophila model of fragile X syndrome.

Authors:  Charles R Tessier; Kendal Broadie
Journal:  Results Probl Cell Differ       Date:  2012

7.  Astrocytes prevent abnormal neuronal development in the fragile x mouse.

Authors:  Shelley Jacobs; Laurie C Doering
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

8.  Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration.

Authors:  Laura N Smith; Jakub P Jedynak; Miles R Fontenot; Carly F Hale; Karen C Dietz; Makoto Taniguchi; Feba S Thomas; Benjamin C Zirlin; Shari G Birnbaum; Kimberly M Huber; Mark J Thomas; Christopher W Cowan
Journal:  Neuron       Date:  2014-05-07       Impact factor: 17.173

Review 9.  Lithium: a promising treatment for fragile X syndrome.

Authors:  Zhonghua Liu; Carolyn Beebe Smith
Journal:  ACS Chem Neurosci       Date:  2014-05-15       Impact factor: 4.418

10.  Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A convergently regulate the synaptic ratio of ionotropic glutamate receptor subclasses.

Authors:  Luyuan Pan; Kendal S Broadie
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.